Clinigen Group plc (‘Clinigen’ or the ‘Group’) (AIM: CLIN), the global specialty pharmaceuticals business, has today published its preliminary results for the 12 months ended 30 June 2013.
Financial highlights
•Group revenue up by 49% to £122.6m (FY12: £82.1m) driven by strong organic growth across all three operational businesses ?Clinigen CTS full year sales up 49% to £87.8m and full year gross profit up 13% to £11.4m
Help employers find you! Check out all the jobs and post your resume.
